| Literature DB >> 31280290 |
J P G van der Ven1,2, Z Sadighy1, E R Valsangiacomo Buechel3, S Sarikouch4, D Robbers-Visser5, C J Kellenberger6, T Kaiser3, P Beerbaum7, E Boersma8, W A Helbing1,9.
Abstract
AIMS: Cardiovascular magnetic resonance (CMR) imaging is an important tool in the assessment of paediatric cardiac disease. Reported reference values of ventricular volumes and masses in the paediatric population are based on small cohorts and several methodologic differences between studies exist. We sought to create steady-state free precession (SSFP) CMR reference values for biventricular volumes and mass by combining data of previously published studies and re-analysing these data in a standardized manner. METHODS ANDEntities:
Keywords: CMR imaging; MRI; congenital heart disease; paediatrics; reference values
Mesh:
Year: 2020 PMID: 31280290 PMCID: PMC6923680 DOI: 10.1093/ehjci/jez164
Source DB: PubMed Journal: Eur Heart J Cardiovasc Imaging ISSN: 2047-2404 Impact factor: 6.875
Population descriptions and CMR parameters of original publications
| Robbers-Visser | Sarikouch | Valsangiacomo-Buechel | Current study | |
|---|---|---|---|---|
|
| 60 | 29 | 50 | 141 |
| Male (%) | 50 | 48 | 46 | 48 |
| Age (year) | Range 8–17 | 12.1 ± 3.8 | Median 11 (range 0.7–18) | Median 12.7 IQR 9.5–14.8 Range 0.6–18.5 |
| MR scanner | 1.5T whole-body (General Electric, Milwaukee, USA) | 1.5T whole-body (Philips Medical Systems, Eindhoven, the Netherlands) | 1.5T whole-body (General Electric, Milwaukee, USA) | |
| Breath-holds | End-expiratory | End-expiratory | End-expiratory ( | |
| Slice thickness (mm) | 7–10 | 5–6 | 5–8 | |
| Interslice gap (mm) | 0 | 0 | 0–2 | |
| Spatial resolution (mm) | 1.8–2.3 × 2.2–2.9 | 2.0–2.5 × 1.5–1.8 | 1.1–1.6 × 1.1–1.6 | |
| TR (ms) | 31.5 | 14–36 | 21–45 |
Seven subjects were included and five were excluded following publication of the original articles.
IQR, inter-quartile range; TR, true temporal resolution (temporal resolution times k-space segments per segment).
Subject characteristics
| Age, years | Weight, kg | Height, cm | BMI, kg/m2 | Heart rate, bpm | BSA, m2 | |
|---|---|---|---|---|---|---|
| Total | ||||||
| Girls ( | 12.5 [9.1–14.9] | 46.0 [30.0–55.0] | 158 [137–166] | 17.5 [16.2–20.3] | 80 [71–89] | 1.41 [1.05–1.60] |
| Boys ( | 12.8 [9.8–14.7] | 43.5 [33.3–62.2] | 158 [140–174] | 18.2 [16.5–20.4] | 81 [73–92] | 1.40 [1.16–1.73] |
| 0 to 6y | ||||||
| Girls ( | 1.8 [1.2–3.3] | 13.2 [9.1–15.5] | 86 [74–97] | 16.1 [15.8–16.4] | 113 [95–134] | 0.43 [0.40–0.48] |
| Boys ( | 0.9 [0.8–1.3] | 9.1 [8.6–10.4] | 77 [73–81] | 18.0 [16.4–18.1] | 110 [106–121] | 0.55 [0.41–0.64] |
| 6 to 12y | ||||||
| Girls ( | 9.6 [8.5–11.3] | 33.0 [28.2–39.0] | 142 [132–146] | 16.4 [15.1–17.8] | 85 [77–90] | 1.13 [1.02–1.24] |
| Boys ( | 9.9 [8.9–11.1] | 33.8 [28.2–36.1] | 142 [134–149] | 16.2 [15.4–17.2] | 84 [75–94] | 1.17 [1.04–1.25] |
| 12 to 18y | ||||||
| Girls ( | 14.8 [13.3–16.4] | 53.0 [48.8–58.3] | 165 [162–170] | 19.8 [18.1–21.6] | 73 [69–81] | 1.59 [1.51–1.67] |
| Boys ( | 14.7 [13.4–16.5] | 62.0 [52.0–68.6] | 173 [166–180] | 20.1 [18.8–22.0] | 77 [67–86] | 1.73 [1.58–1.87] |
Absolute volumes and masses of the LV and RV
| Variables | Total population | 0-6 year | 6–12 years | 12–18 years | ||||
|---|---|---|---|---|---|---|---|---|
| Girls | Boys | Girls | Boys | Girls | Boys | Girls | Boys | |
| ( | ( | ( | ( | ( | ( | ( | ( | |
| LV EDV (mL) | 92 [68–113] | 99 [85–142] | 25 [20–30] | 22 [21–24] | 77 [61–89] | 86 [76–94] | 112 [102–124] | 140 [120–161] |
| LV ESV (mL) | 35 [23–39] | 31 [26–51] | 9 [7–10] | 6 [5–7] | 27 [21–32] | 27 [21–31] | 38 [35–46] | 51 [34–59] |
| LV SV (mL) | 61 [41–74] | 70 [57–90] | 16 [12–22] | 17 [15–17] | 49 [40–56] | 57 [54–63] | 74 [65–81] | 89 [72–107] |
| LV EF (%) | 65 [61–69] | 67 [63–72] | 63 [61–68] | 73 [71–74] | 65 [60–68] | 69 [65–73] | 66 [62–69] | 66 [63–71] |
| LV mass(g) | 69 [49–88] | 82 [58–120] | 21 [16–26] | 18 [15–21] | 58 [43–65] | 58 [49–72] | 87 [77–96] | 122 [101–137] |
| RV EDV (mL) | 98 [72–120] | 110 [90–155] | 23 [18–31] | 23 [21–26] | 82 [63–88] | 94 [82–104] | 119 [108–134] | 155 [132–183] |
| RV ESV (mL) | 38 [26–46] | 43 [32–69] | 8 [6–10] | 6 [5–8] | 30 [22–34] | 35 [28–38] | 44 [40–54] | 68 [49–76] |
| RV SV (mL) | 63 [41–75] | 68 [56–89] | 16 [13–23] | 18 [16–20] | 47 [38–54] | 58 [51–64] | 74 [64–85] | 89 [72–104] |
| RV EF (%) | 63 [58–67] | 61 [57–67] | 68 [63–71] | 71 [69–75] | 61 [56–66] | 64 [60–68] | 62 [57–65] | 59 [56–62] |
| RV mass (g) | 25 [13–29] | 28 [17–44] | 6 [4–9] | 5 [4–6] | 17 [12–25] | 21 [14–26] | 29 [25–34] | 42 [30–52] |
EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricle; RV, right ventricle; SV, stroke volume.
P < 0.05; **P < 0.01; **P < 0.001 for differences between genders.
Volumes and masses of the LV and RV, indexed for BSA
| Variables | Total population | 0–6 year | 6–12 years | 12–18 years | ||||
|---|---|---|---|---|---|---|---|---|
| Girls | Boys | Girls | Boys | Girls | Boys | Girls | Boys | |
| ( | ( | ( | ( | ( | ( | ( | ( | |
| LV EDV(mL/m2) | 68 [59–73] | 76 [68–83] | 48 [44–51] | 51 [50–52] | 65 [60–70] | 75 [67–77] | 71 [68–77] | 82 [73–89] |
| LV ESV(mL/m2) | 23 [20–27] | 24 [21–29] | 17 [16–22] | 13 [ 13–15] | 22 [20–27] | 23 [21–25] | 24 [22–28] | 27 [22–33] |
| LV SV(mL/m2) | 44 [40–48] | 51 [45–57] | 32 [28–35] | 36 [34–38] | 43 [40–45] | 50 [45–56] | 47 [43–51] | 52 [47–58] |
| LV mass(g/m2) | 49 [42–58] | 60 [49–69] | 40 [38–42] | 38 [35–40] | 46 [42–54] | 53 [44–58] | 53 [46–61] | 67 [61–75] |
| RV EDV(mL/m2) | 69 [63–79] | 82 [74–92] | 47 [41–53] | 54 [52–55] | 68 [62–72] | 79 [74–84] | 78 [69–84] | 90 [81–96] |
| RV ESV(mL/m2) | 26 [22–31] | 31 [27–38] | 16 [14–18] | 15 [13–16] | 25 [23–30] | 29 [26–32] | 29 [25–34] | 37 [30–40] |
| RV SV(mL/m2) | 43 [37–49] | 51 [44–55] | 32 [28–37] | 38 [36–40] | 42 [37–46] | 51 [45–54] | 49 [41–52] | 51 [46–56] |
| RV mass(g/m2) | 17 [13–20] | 20 [15–25] | 12 [9–14] | 11 [ 10–11] | 14 [12–19] | 17 [14–21] | 18 [16–22] | 23 [19–28] |
EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume; LV, left ventricle; RV, right ventricle; SV, stroke volume.
P < 0.05; **P < 0.01; ***P < 0.001 for differences between genders.
Inter-observer and intra-observer variability
| Mean difference | Limits of agreement | COV (%) | ICC | |
|---|---|---|---|---|
| Inter-observer variability | ||||
| LV EDV (mL) | 8.4 | −27.7 to 11 | 8.2 | 0.97 |
| LV ESV (mL) | 8.8 | −17.9 to 0.4 | 21.1 | 0.97 |
| LV SV (mL) | 0.2 | −18.9 to 18.5 | 1.4 | 0.94 |
| LV EF (%) | 4.5 | −5.1 to 14.1 | 8.2 | 0.59 |
| LV mass (g) | 9.7 | −16.1 to 35.4 | 12.1 | 0.94 |
| RV EDV (mL) | 4.1 | −37.4 to 29.3 | 6.0 | 0.93 |
| RV ESV (mL) | 4.7 | −19.2 to 9.8 | 9.9 | 0.94 |
| RV SV (mL) | 1.1 | −26.5 to 24.3 | 3.3 | 0.88 |
| RV EF (%) | 1.6 | −10.6 to 13.8 | 6.0 | 0.51 |
| RV mass (g) | 3.5 | −52.4 to 34.9 | 5.9 | 0.50 |
| Intra-observer variability | ||||
| LV EDV (mL) | 1.0 | −19.8 to 17.9 | 1.0 | 0.97 |
| LV ESV (mL) | 1.2 | −11.0 to 13.4 | 7.3 | 0.95 |
| LV SV (mL) | 2.2 | −22.9 to 18.6 | 4.6 | 0.92 |
| LV EF (%) | 2.5 | −12.5 to 7.5 | 1.0 | 0.70 |
| LV mass (g) | 2.4 | −28.3 to 23.5 | 0.1 | 0.96 |
| RV EDV (mL) | 5.0 | −33.4 to 23.3 | 4.2 | 0.95 |
| RV ESV (mL) | 3.3 | −19.1 to 12.6 | 4.5 | 0.94 |
| RV SV (mL) | 1.8 | −25.6 to 22.0 | 3.7 | 0.90 |
| RV EF (%) | 0.2 | −10.4 to 10.8 | 4.2 | 0.67 |
| RV mass (g) | 1.2 | −20.0 to 22.4 | 0.3 | 0.82 |
COV, coefficient of variation; EDV, end-diastolic volume; ESV, end-systolic volume; ICC, intra-class correlation coefficient; LV, left ventricle; RV, right ventricle; SV, stroke volume.